I would love to see LTC get into the surgeons hands for the specialized surgeries like lung surgery but it has a long way to go to get FDA approved for elaborate surgeries and then get market acceptance which will make it very hard to make a good deal in these market conditions IMHO. I do wish the best for those who hold on but I think it is unrealistic to think this is going anywhere, anytime soon. If they could sell the LTC company, then there would be some hope but as lowman has pointed out CTGI has the exclusive rights to "Market LTC" with 14% of the sales going back to the Ukraine where they own the patents. Without ownership of the patents it will be tough to get a good deal IMHO.
Would I look at getting back into this stock? Maybe but more details of what the new management is getting and the dilution situation needs to be known. Remember, they only have a couple of months before the lawsuit shares become unrestricted and CTGI is not in the high-volume upward trend that it was in Dec.
Market Data 
Markets 
